Journal of the American Society of Nephrology, ISSN 1046-6673, 04/2006, Volume 17, Issue 2, pp. S145 - S147
Chronic renal disease is accompanied by characteristic abnormalities of lipid metabolism, which appear as a consequence of nephrotic syndrome or renal...
RISK-FACTORS | CHOLESTEROL | MICROALBUMINURIA | CARDIOVASCULAR-DISEASE | RESISTANCE | UROLOGY & NEPHROLOGY | NEPHROPATHY | LIPOPROTEINS | BLOOD-PRESSURE | INSULIN-DEPENDENT DIABETICS | MOLECULAR-MECHANISMS | Lipids - chemistry | Hydroxymethylglutaryl-CoA Reductase Inhibitors - pharmacology | Kidney Failure, Chronic - diagnosis | Kidney Failure, Chronic - blood | Kidney Failure, Chronic - epidemiology | Humans | Kidney Failure, Chronic - drug therapy | Risk Factors | Lipid Metabolism | Cholesterol - metabolism | Disease Progression | Triglycerides - metabolism
RISK-FACTORS | CHOLESTEROL | MICROALBUMINURIA | CARDIOVASCULAR-DISEASE | RESISTANCE | UROLOGY & NEPHROLOGY | NEPHROPATHY | LIPOPROTEINS | BLOOD-PRESSURE | INSULIN-DEPENDENT DIABETICS | MOLECULAR-MECHANISMS | Lipids - chemistry | Hydroxymethylglutaryl-CoA Reductase Inhibitors - pharmacology | Kidney Failure, Chronic - diagnosis | Kidney Failure, Chronic - blood | Kidney Failure, Chronic - epidemiology | Humans | Kidney Failure, Chronic - drug therapy | Risk Factors | Lipid Metabolism | Cholesterol - metabolism | Disease Progression | Triglycerides - metabolism
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2004, Volume 351, Issue 19, pp. 1941 - 1951
In a multicenter, double-blind, placebo-controlled, randomized study, subjects with type 2 diabetes mellitus and hypertension but normal urinary albumin levels...
MORTALITY | MEDICINE, GENERAL & INTERNAL | LOSARTAN | ALBUMIN EXCRETION | CLINICAL PROTEINURIA | RENAL-DISEASE | MELLITUS | INHIBITORS | IRBESARTAN | NEPHROPATHY | PROGRESSION | Double-Blind Method | Humans | Middle Aged | Calcium Channel Blockers - therapeutic use | Proportional Hazards Models | Hypertension - drug therapy | Male | Treatment Outcome | Albuminuria - prevention & control | Antihypertensive Agents - therapeutic use | Disease Progression | Verapamil - therapeutic use | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Hypertension - complications | Adult | Female | Indoles - therapeutic use | Aged | Diabetes Mellitus, Type 2 - drug therapy | Drug Therapy, Combination | Diabetes Mellitus, Type 2 - complications | Type 2 diabetes | Care and treatment | Research | Albuminuria | ACE inhibitors | Risk factors | Hypertension | Blood pressure | Heart attacks | Statistical analysis | Diabetes
MORTALITY | MEDICINE, GENERAL & INTERNAL | LOSARTAN | ALBUMIN EXCRETION | CLINICAL PROTEINURIA | RENAL-DISEASE | MELLITUS | INHIBITORS | IRBESARTAN | NEPHROPATHY | PROGRESSION | Double-Blind Method | Humans | Middle Aged | Calcium Channel Blockers - therapeutic use | Proportional Hazards Models | Hypertension - drug therapy | Male | Treatment Outcome | Albuminuria - prevention & control | Antihypertensive Agents - therapeutic use | Disease Progression | Verapamil - therapeutic use | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Hypertension - complications | Adult | Female | Indoles - therapeutic use | Aged | Diabetes Mellitus, Type 2 - drug therapy | Drug Therapy, Combination | Diabetes Mellitus, Type 2 - complications | Type 2 diabetes | Care and treatment | Research | Albuminuria | ACE inhibitors | Risk factors | Hypertension | Blood pressure | Heart attacks | Statistical analysis | Diabetes
Journal Article
The Lancet Diabetes & Endocrinology, ISSN 2213-8587, 11/2017, Volume 5, Issue 11, pp. 887 - 897
The best treatment option for patients with type 2 diabetes in whom treatment with metformin alone fails to achieve adequate glycaemic control is debated. We...
MORTALITY | INSULIN | GLYCEMIC CONTROL | IMPACT | METAANALYSIS | GLUCOSE-LOWERING DRUGS | ENDOCRINOLOGY & METABOLISM | FOLLOW-UP | RISK | GLIMEPIRIDE | Hypoglycemic Agents - therapeutic use | Cardiovascular Diseases - etiology | Metformin - therapeutic use | Cardiovascular Diseases - drug therapy | Humans | Middle Aged | Pioglitazone | Sulfonylurea Compounds - therapeutic use | Male | Treatment Outcome | Diabetes Mellitus, Type 2 - epidemiology | Incidence | Thiazolidinediones - therapeutic use | Cardiovascular Diseases - epidemiology | Female | Aged | Drug Therapy, Combination | Diabetes Mellitus, Type 2 - complications
MORTALITY | INSULIN | GLYCEMIC CONTROL | IMPACT | METAANALYSIS | GLUCOSE-LOWERING DRUGS | ENDOCRINOLOGY & METABOLISM | FOLLOW-UP | RISK | GLIMEPIRIDE | Hypoglycemic Agents - therapeutic use | Cardiovascular Diseases - etiology | Metformin - therapeutic use | Cardiovascular Diseases - drug therapy | Humans | Middle Aged | Pioglitazone | Sulfonylurea Compounds - therapeutic use | Male | Treatment Outcome | Diabetes Mellitus, Type 2 - epidemiology | Incidence | Thiazolidinediones - therapeutic use | Cardiovascular Diseases - epidemiology | Female | Aged | Drug Therapy, Combination | Diabetes Mellitus, Type 2 - complications
Journal Article
FRONTIERS IN GENETICS, ISSN 1664-8021, 07/2019, Volume 10, p. 681
Complement activation has been increasingly implicated in the pathogenesis of type 2 diabetes and its chronic complications. It is unknown whether complement...
ACTIVATION | HEMOLYTIC-UREMIC SYNDROME | SUSCEPTIBILITY | RISK | diabetes complications | factor H | BLOOD-PRESSURE | microalbuminuria | CFH POLYMORPHISMS | DISEASE | GENETICS & HEREDITY | COMPLICATIONS | cardiovascular risk | complement | KIDNEY | diabetes | ACE inhibitors | Type 2 diabetes | Dosage and administration | Genetic aspects | Drug therapy | Risk factors | Enzyme inhibitors | Trandolapril | Diabetes therapy
ACTIVATION | HEMOLYTIC-UREMIC SYNDROME | SUSCEPTIBILITY | RISK | diabetes complications | factor H | BLOOD-PRESSURE | microalbuminuria | CFH POLYMORPHISMS | DISEASE | GENETICS & HEREDITY | COMPLICATIONS | cardiovascular risk | complement | KIDNEY | diabetes | ACE inhibitors | Type 2 diabetes | Dosage and administration | Genetic aspects | Drug therapy | Risk factors | Enzyme inhibitors | Trandolapril | Diabetes therapy
Journal Article
Diabetes Care, ISSN 0149-5992, 06/2010, Volume 33, Issue 6, pp. e81 - e81
Journal Article
Diabetes Care, ISSN 0149-5992, 04/2003, Volume 26, Issue 4, pp. 1321 - 1322
GLYCEMIC CONTROL | ENDOCRINOLOGY & METABOLISM | Hypoglycemic Agents - therapeutic use | Reproducibility of Results | Insulin, Long-Acting | Drug Administration Schedule | Glycated Hemoglobin A - metabolism | Humans | Insulin - administration & dosage | Male | Diabetes Mellitus, Type 1 - drug therapy | Insulin Lispro | Blood Glucose - drug effects | Hypoglycemic Agents - administration & dosage | Insulin Glargine | Diabetes Mellitus, Type 1 - blood | Injections, Subcutaneous | Age of Onset | Adult | Female | Insulin Infusion Systems | Insulin - analogs & derivatives | Blood Glucose - metabolism | Insulin - therapeutic use
Journal Article
Nutrition, Metabolism and Cardiovascular Diseases, ISSN 0939-4753, 09/2006, Volume 16, Issue 6, pp. e1 - e3
Journal Article
Diabetes Care, ISSN 0149-5992, 2006, Volume 29, Issue 8, pp. 1985 - 1985
Although there is a strong association between lower-extremity amputation (LEA) and HbA^sub 1c^ (A1C) in diabetic patients (1,2), little information is...
ENDOCRINOLOGY & METABOLISM | Diabetic Foot - metabolism | Diabetic Foot - epidemiology | Humans | Amputation | Diabetic Foot - drug therapy | Diabetic Foot - surgery | Female | Male | Aged | Blood Glucose - metabolism | Care and treatment | Diagnosis | Glucose tolerance tests | Diabetic ulcers | Ulcers | Hospitalization | Glucose | Diabetes | Patients | Feet
ENDOCRINOLOGY & METABOLISM | Diabetic Foot - metabolism | Diabetic Foot - epidemiology | Humans | Amputation | Diabetic Foot - drug therapy | Diabetic Foot - surgery | Female | Male | Aged | Blood Glucose - metabolism | Care and treatment | Diagnosis | Glucose tolerance tests | Diabetic ulcers | Ulcers | Hospitalization | Glucose | Diabetes | Patients | Feet
Journal Article
Diabetes Care, ISSN 0149-5992, 04/2003, Volume 26, Issue 4, p. 1321
Journal Article
Giornale Italiano di Diabetologia e Metabolismo, ISSN 1593-6104, 12/2013, Volume 33, Issue 4, pp. 204 - 208
Journal Article
Diabetes Care, ISSN 0149-5992, 2006, Volume 29, Issue 2, pp. 432 - 434
Because of its devastating outcomes, including end-stage renal disease and increased cardiovascular morbidity and mortality, chronic kidney disease is a...
CARDIOVASCULAR-DISEASE | RISK-FACTORS | MICROALBUMINURIA | ENDOCRINOLOGY & METABOLISM | RENAL-INSUFFICIENCY | Diabetes Mellitus, Type 2 - physiopathology | Insulin Resistance - physiology | Humans | Middle Aged | Metabolic Syndrome - physiopathology | Adult | Female | Male | Aged | Glomerular Filtration Rate - physiology | Kidney - physiopathology | Type 2 diabetes | Diagnosis | Metabolic syndrome X | Health aspects | Risk factors | Insulin | Kidney diseases
CARDIOVASCULAR-DISEASE | RISK-FACTORS | MICROALBUMINURIA | ENDOCRINOLOGY & METABOLISM | RENAL-INSUFFICIENCY | Diabetes Mellitus, Type 2 - physiopathology | Insulin Resistance - physiology | Humans | Middle Aged | Metabolic Syndrome - physiopathology | Adult | Female | Male | Aged | Glomerular Filtration Rate - physiology | Kidney - physiopathology | Type 2 diabetes | Diagnosis | Metabolic syndrome X | Health aspects | Risk factors | Insulin | Kidney diseases
Journal Article
Diabetes Care, ISSN 0149-5992, 07/2005, Volume 28, Issue 7, pp. 1834 - 1835
SEVERE HYPOGLYCEMIA | METABOLIC-CONTROL | PUMP THERAPY | ADOLESCENTS | ENDOCRINOLOGY & METABOLISM | Hypoglycemic Agents - therapeutic use | Age Factors | Drug Administration Schedule | Glycated Hemoglobin A - metabolism | Humans | Insulin - administration & dosage | Male | Diabetes Mellitus, Type 1 - drug therapy | Hypoglycemic Agents - administration & dosage | Diabetes Mellitus, Type 1 - blood | Adult | Female | Insulin Infusion Systems | Retrospective Studies | Insulin - therapeutic use | Dosage and administration | Diabetes | Drug therapy | Insulin
Journal Article
Diabetes Care, ISSN 0149-5992, 07/2007, Volume 30, Issue 7, pp. e60 - e60
Hypoglycemic Agents - administration & dosage | Humans | Injections, Subcutaneous | Middle Aged | Postprandial Period | Adult | Insulin - administration & dosage | Blood Pressure - physiology | Hyperglycemia - etiology | Diabetes Mellitus, Type 1 - complications | Hyperglycemia - physiopathology | Diabetes Mellitus, Type 1 - drug therapy
Journal Article
Acta Oncologica, ISSN 0284-186X, 2007, Volume 46, Issue 1, pp. 118 - 120
Journal Article
Giornale Italiano di Diabetologia e Metabolismo, ISSN 1593-6104, 06/2010, Volume 30, Issue 2, pp. 56 - 60
Journal Article
16.
Full Text
Effect of pancreas transplantation on free fatty acid metabolism in uremic IDDM patients
Diabetes, ISSN 0012-1797, 1996, Volume 45, Issue 3, pp. 354 - 360
To assess the effect of pancreas transplantation on free fatty acid (FFA) and glucose metabolism, we studied seven uremic IDDM patients (HbA(1c) 9.1%), nine...
DEXAMETHASONE | RAT HEPATOCYTES | KIDNEY-TRANSPLANTATION | INSULIN-RESISTANCE | GLUCOSE | KINETICS | DEPENDENT DIABETIC-PATIENTS | ENDOCRINOLOGY & METABOLISM | FOLLOW-UP | HYPERINSULINEMIA | RECEPTOR | Physiological aspects | Glucose metabolism | Transplantation | Fatty acid metabolism | Pancreas | Type 1 diabetes
DEXAMETHASONE | RAT HEPATOCYTES | KIDNEY-TRANSPLANTATION | INSULIN-RESISTANCE | GLUCOSE | KINETICS | DEPENDENT DIABETIC-PATIENTS | ENDOCRINOLOGY & METABOLISM | FOLLOW-UP | HYPERINSULINEMIA | RECEPTOR | Physiological aspects | Glucose metabolism | Transplantation | Fatty acid metabolism | Pancreas | Type 1 diabetes
Journal Article
Diabetes Care, ISSN 0149-5992, 10/2012, Volume 35, Issue 10, pp. 2061 - 2068
OBJECTIVE-To describe the prevalence and determinants of hyperfiltration (glomerular Nitration rate [GFR] >= 120 mL/min/1.73 m(2)), GFR decline, and...
KIDNEY-DISEASE | FUNCTION DECLINE | GLYCEMIC CONTROL | ALBUMIN EXCRETION | ENDOCRINOLOGY & METABOLISM | FILTRATION-RATE | LONGITUDINAL DATA | PREDICTION EQUATIONS | PLASMA-CLEARANCE | AFRICAN-AMERICAN | ANTIHYPERTENSIVE TREATMENT | Albuminuria - complications | Diabetic Nephropathies - etiology | Humans | Middle Aged | Kidney Glomerulus - physiopathology | Blood Glucose | Male | Glomerular Filtration Rate - physiology | Diabetes Mellitus, Type 2 - physiopathology | Female | Aged | Diabetes Mellitus, Type 2 - complications | Cohort Studies | Type 2 diabetes | Hypertension | Medical research | Medicine, Experimental | Development and progression | Research | Kidney diseases | Studies | Kidneys | Diabetes | Disease | Original Research
KIDNEY-DISEASE | FUNCTION DECLINE | GLYCEMIC CONTROL | ALBUMIN EXCRETION | ENDOCRINOLOGY & METABOLISM | FILTRATION-RATE | LONGITUDINAL DATA | PREDICTION EQUATIONS | PLASMA-CLEARANCE | AFRICAN-AMERICAN | ANTIHYPERTENSIVE TREATMENT | Albuminuria - complications | Diabetic Nephropathies - etiology | Humans | Middle Aged | Kidney Glomerulus - physiopathology | Blood Glucose | Male | Glomerular Filtration Rate - physiology | Diabetes Mellitus, Type 2 - physiopathology | Female | Aged | Diabetes Mellitus, Type 2 - complications | Cohort Studies | Type 2 diabetes | Hypertension | Medical research | Medicine, Experimental | Development and progression | Research | Kidney diseases | Studies | Kidneys | Diabetes | Disease | Original Research
Journal Article
Nephron, ISSN 1660-8151, 07/2017, Volume 136, Issue 4, pp. 277 - 280
Hyperfiltering kidney is a typical feature of diabetes. Improvement observed with regard to glucose control and blood pressure control reduces the high...
Diabetic nephropathy | Intraglomerular pressure | Diabetes | Hyperfiltration | RENAL HYPERFILTRATION | TUBULAR REABSORPTION | SIZE | MELLITUS | GLOMERULAR-FILTRATION-RATE | INHIBITION | DISEASE | UROLOGY & NEPHROLOGY | PROGRESSION | EMPAGLIFLOZIN | Diabetes Mellitus, Type 2 - physiopathology | Diabetic Nephropathies - physiopathology | Glomerular Filtration Rate | Humans | Diabetic Nephropathies - drug therapy | Disease Progression | Kidney - physiopathology | Sodium-Glucose Transporter 2 - antagonists & inhibitors
Diabetic nephropathy | Intraglomerular pressure | Diabetes | Hyperfiltration | RENAL HYPERFILTRATION | TUBULAR REABSORPTION | SIZE | MELLITUS | GLOMERULAR-FILTRATION-RATE | INHIBITION | DISEASE | UROLOGY & NEPHROLOGY | PROGRESSION | EMPAGLIFLOZIN | Diabetes Mellitus, Type 2 - physiopathology | Diabetic Nephropathies - physiopathology | Glomerular Filtration Rate | Humans | Diabetic Nephropathies - drug therapy | Disease Progression | Kidney - physiopathology | Sodium-Glucose Transporter 2 - antagonists & inhibitors
Journal Article
Journal of the American Society of Nephrology, ISSN 1046-6673, 09/2012, Volume 23, Issue 10, pp. 1717 - 1724
Micro- or macroalbuminuria is associated with increased cardiovascular risk factors among patients with type 2 diabetes, but whether albuminuria within the...
TRIAL | MORTALITY | HEART-DISEASE | EVENTS | ENDOTHELIAL DYSFUNCTION | MICROALBUMINURIA | UROLOGY & NEPHROLOGY | BLOOD-PRESSURE CONTROL | NONDIABETIC INDIVIDUALS | COMPLICATIONS | NEPHROPATHY | Albuminuria - complications | Cardiovascular Diseases - etiology | Biomarkers - urine | Humans | Middle Aged | Risk Factors | Male | Cardiotonic Agents - therapeutic use | Verapamil - therapeutic use | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Female | Indoles - therapeutic use | Aged | Albuminuria - urine | Diabetes Mellitus, Type 2 - drug therapy | Longitudinal Studies | Diabetes Mellitus, Type 2 - complications | Clinical Epidemiology
TRIAL | MORTALITY | HEART-DISEASE | EVENTS | ENDOTHELIAL DYSFUNCTION | MICROALBUMINURIA | UROLOGY & NEPHROLOGY | BLOOD-PRESSURE CONTROL | NONDIABETIC INDIVIDUALS | COMPLICATIONS | NEPHROPATHY | Albuminuria - complications | Cardiovascular Diseases - etiology | Biomarkers - urine | Humans | Middle Aged | Risk Factors | Male | Cardiotonic Agents - therapeutic use | Verapamil - therapeutic use | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Female | Indoles - therapeutic use | Aged | Albuminuria - urine | Diabetes Mellitus, Type 2 - drug therapy | Longitudinal Studies | Diabetes Mellitus, Type 2 - complications | Clinical Epidemiology
Journal Article
Diabetes Research and Clinical Practice, ISSN 0168-8227, 2016, Volume 113, pp. 48 - 52
Abstract Aims To describe the degree of diffusion and acceptance of national guideline on screening and diagnosis of gestational diabetes (GDM) among Italian...
Endocrinology & Metabolism | Screening procedure | Diagnostic test | Gestational diabetes | CRITERIA | ENDOCRINOLOGY & METABOLISM | INTERNATIONAL ASSOCIATION | MELLITUS | PREGNANCY | Diabetes, Gestational - diagnosis | Health Plan Implementation | Blood Glucose - analysis | Practice Guidelines as Topic - standards | Humans | Risk Factors | Mass Screening - standards | Diabetes, Gestational - prevention & control | Gestational Age | Mass Screening - methods | Pregnancy | Adult | Female | Italy | Surveys and Questionnaires | Glucose Tolerance Test - standards | Surveys | Practice guidelines (Medicine) | Diabetes in pregnancy | Diagnosis | Public opinion | Health surveys | Glucose tolerance tests
Endocrinology & Metabolism | Screening procedure | Diagnostic test | Gestational diabetes | CRITERIA | ENDOCRINOLOGY & METABOLISM | INTERNATIONAL ASSOCIATION | MELLITUS | PREGNANCY | Diabetes, Gestational - diagnosis | Health Plan Implementation | Blood Glucose - analysis | Practice Guidelines as Topic - standards | Humans | Risk Factors | Mass Screening - standards | Diabetes, Gestational - prevention & control | Gestational Age | Mass Screening - methods | Pregnancy | Adult | Female | Italy | Surveys and Questionnaires | Glucose Tolerance Test - standards | Surveys | Practice guidelines (Medicine) | Diabetes in pregnancy | Diagnosis | Public opinion | Health surveys | Glucose tolerance tests
Journal Article